Chapter/Section Purchase

1 Human Vaccine Market Overview
1.1 Product Overview and Scope of Human Vaccine
1.2 Human Vaccine Segment by Type
1.2.1 Global Human Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Human Vaccine Segment by Application
1.3.1 Global Human Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Adults
1.3.3 Children
1.4 Global Human Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Vaccine Revenue 2016-2027
1.4.2 Global Human Vaccine Sales 2016-2027
1.4.3 Human Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Human Vaccine Market Competition by Manufacturers
2.1 Global Human Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Human Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Human Vaccine Market Competitive Situation and Trends
2.5.1 Human Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Vaccine Players Market Share by Revenue
2.5.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Human Vaccine Retrospective Market Scenario by Region
3.1 Global Human Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Human Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Human Vaccine Market Facts & Figures by Country
3.3.1 North America Human Vaccine Sales by Country
3.3.2 North America Human Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Vaccine Market Facts & Figures by Country
3.4.1 Europe Human Vaccine Sales by Country
3.4.2 Europe Human Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Human Vaccine Sales by Region
3.5.2 Asia Pacific Human Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Vaccine Market Facts & Figures by Country
3.6.1 Latin America Human Vaccine Sales by Country
3.6.2 Latin America Human Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Vaccine Sales by Country
3.7.2 Middle East and Africa Human Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Vaccine Historic Market Analysis by Type
4.1 Global Human Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Human Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Human Vaccine Price by Type (2016-2021)

5 Global Human Vaccine Historic Market Analysis by Application
5.1 Global Human Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Human Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Human Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 CNBG
6.1.1 CNBG Corporation Information
6.1.2 CNBG Description and Business Overview
6.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CNBG Human Vaccine Product Portfolio
6.1.5 CNBG Recent Developments/Updates
6.2 Changsheng Life
6.2.1 Changsheng Life Corporation Information
6.2.2 Changsheng Life Description and Business Overview
6.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Changsheng Life Human Vaccine Product Portfolio
6.2.5 Changsheng Life Recent Developments/Updates
6.3 Zhifei
6.3.1 Zhifei Corporation Information
6.3.2 Zhifei Description and Business Overview
6.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Zhifei Human Vaccine Product Portfolio
6.3.5 Zhifei Recent Developments/Updates
6.4 ChengDa Bio
6.4.1 ChengDa Bio Corporation Information
6.4.2 ChengDa Bio Description and Business Overview
6.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 ChengDa Bio Human Vaccine Product Portfolio
6.4.5 ChengDa Bio Recent Developments/Updates
6.5 Kangtai
6.5.1 Kangtai Corporation Information
6.5.2 Kangtai Description and Business Overview
6.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kangtai Human Vaccine Product Portfolio
6.5.5 Kangtai Recent Developments/Updates
6.6 SINOVAC BIOTECH
6.6.1 SINOVAC BIOTECH Corporation Information
6.6.2 SINOVAC BIOTECH Description and Business Overview
6.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 SINOVAC BIOTECH Human Vaccine Product Portfolio
6.6.5 SINOVAC BIOTECH Recent Developments/Updates
6.7 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hissen Human Vaccine Product Portfolio
6.7.5 Hissen Recent Developments/Updates
6.8 Walvax Biotechnology
6.8.1 Walvax Biotechnology Corporation Information
6.8.2 Walvax Biotechnology Description and Business Overview
6.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Walvax Biotechnology Human Vaccine Product Portfolio
6.8.5 Walvax Biotechnology Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 GSK Human Vaccine Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 SANOFI
6.10.1 SANOFI Corporation Information
6.10.2 SANOFI Description and Business Overview
6.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 SANOFI Human Vaccine Product Portfolio
6.10.5 SANOFI Recent Developments/Updates
6.11 Rong An
6.11.1 Rong An Corporation Information
6.11.2 Rong An Human Vaccine Description and Business Overview
6.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Rong An Human Vaccine Product Portfolio
6.11.5 Rong An Recent Developments/Updates
6.12 NuoCheng Bio
6.12.1 NuoCheng Bio Corporation Information
6.12.2 NuoCheng Bio Human Vaccine Description and Business Overview
6.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 NuoCheng Bio Human Vaccine Product Portfolio
6.12.5 NuoCheng Bio Recent Developments/Updates
6.13 Hualan Bio
6.13.1 Hualan Bio Corporation Information
6.13.2 Hualan Bio Human Vaccine Description and Business Overview
6.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Hualan Bio Human Vaccine Product Portfolio
6.13.5 Hualan Bio Recent Developments/Updates
6.14 Tiantan biological
6.14.1 Tiantan biological Corporation Information
6.14.2 Tiantan biological Human Vaccine Description and Business Overview
6.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Tiantan biological Human Vaccine Product Portfolio
6.14.5 Tiantan biological Recent Developments/Updates
6.15 Changchun Baike
6.15.1 Changchun Baike Corporation Information
6.15.2 Changchun Baike Human Vaccine Description and Business Overview
6.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Changchun Baike Human Vaccine Product Portfolio
6.15.5 Changchun Baike Recent Developments/Updates
6.16 Adimmune
6.16.1 Adimmune Corporation Information
6.16.2 Adimmune Human Vaccine Description and Business Overview
6.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Adimmune Human Vaccine Product Portfolio
6.16.5 Adimmune Recent Developments/Updates
6.17 Zhongyianke Biotech
6.17.1 Zhongyianke Biotech Corporation Information
6.17.2 Zhongyianke Biotech Human Vaccine Description and Business Overview
6.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Zhongyianke Biotech Human Vaccine Product Portfolio
6.17.5 Zhongyianke Biotech Recent Developments/Updates
6.18 Bharat Biotech
6.18.1 Bharat Biotech Corporation Information
6.18.2 Bharat Biotech Human Vaccine Description and Business Overview
6.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Bharat Biotech Human Vaccine Product Portfolio
6.18.5 Bharat Biotech Recent Developments/Updates
6.19 Bavarian Nordic
6.19.1 Bavarian Nordic Corporation Information
6.19.2 Bavarian Nordic Human Vaccine Description and Business Overview
6.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Bavarian Nordic Human Vaccine Product Portfolio
6.19.5 Bavarian Nordic Recent Developments/Updates
6.20 Sanofi-Pasteur
6.20.1 Sanofi-Pasteur Corporation Information
6.20.2 Sanofi-Pasteur Human Vaccine Description and Business Overview
6.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Sanofi-Pasteur Human Vaccine Product Portfolio
6.20.5 Sanofi-Pasteur Recent Developments/Updates
6.21 Indian Immunologicals
6.21.1 Indian Immunologicals Corporation Information
6.21.2 Indian Immunologicals Human Vaccine Description and Business Overview
6.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Indian Immunologicals Human Vaccine Product Portfolio
6.21.5 Indian Immunologicals Recent Developments/Updates
6.22 KANGH
6.22.1 KANGH Corporation Information
6.22.2 KANGH Human Vaccine Description and Business Overview
6.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.22.4 KANGH Human Vaccine Product Portfolio
6.22.5 KANGH Recent Developments/Updates
6.23 Henan Grand Biopharma
6.23.1 Henan Grand Biopharma Corporation Information
6.23.2 Henan Grand Biopharma Human Vaccine Description and Business Overview
6.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Henan Grand Biopharma Human Vaccine Product Portfolio
6.23.5 Henan Grand Biopharma Recent Developments/Updates
6.24 ZhongKe Biopharm
6.24.1 ZhongKe Biopharm Corporation Information
6.24.2 ZhongKe Biopharm Human Vaccine Description and Business Overview
6.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.24.4 ZhongKe Biopharm Human Vaccine Product Portfolio
6.24.5 ZhongKe Biopharm Recent Developments/Updates
6.25 Zhuoyi Biological
6.25.1 Zhuoyi Biological Corporation Information
6.25.2 Zhuoyi Biological Human Vaccine Description and Business Overview
6.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.25.4 Zhuoyi Biological Human Vaccine Product Portfolio
6.25.5 Zhuoyi Biological Recent Developments/Updates

7 Human Vaccine Manufacturing Cost Analysis
7.1 Human Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Vaccine
7.4 Human Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Vaccine Distributors List
8.3 Human Vaccine Customers

9 Human Vaccine Market Dynamics
9.1 Human Vaccine Industry Trends
9.2 Human Vaccine Growth Drivers
9.3 Human Vaccine Market Challenges
9.4 Human Vaccine Market Restraints

10 Global Market Forecast
10.1 Human Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Human Vaccine by Type (2022-2027)
10.2 Human Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Human Vaccine by Application (2022-2027)
10.3 Human Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Human Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer